WELCOME TO The HEALTHCARE REPORT
Newsletter | Member Login | Signup
Home > Companies > Riverside HealthCare
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
Healthcare Analytics
Business Wire | October 27, 2023
Keena Healthcare Technology, a healthcare optimization organization, and Altera Digital Health, a global health IT leader, announce today that they have engaged in a reseller agreement. The expanded sales collaboration deal is an extension of the partnership and developer agreement Keena has had with Altera’s TouchWorks® EHR business unit since 2008. Keena has...
PR Newswire | July 14, 2020
In a time of a pandemic, new innovations solutions to health problems are in need. One group of devices that got more attention as a result are wearable devices. The growing popularity of the Internet of Things (IoT) and connected devices, as well as the rising population of more technologically adept persons is expected to drive the demand. Before the pandemic, wearables for medical purposes were also gaining momentum, in part thanks to concerns of obesity and other chronic diseases. This, in p...
Healthtech Security
CareSignal, Health Alliance | June 27, 2022
Health AllianceTM, the health plan of Illinois-based Carle Health, is leading the way for rising-risk populations by launching a remote patient monitoring program powered by CareSignal. This program is part of Hally® health, the member-facing telehealth app Health Alliance uses to give its members access to tools and resources for their well-being. The partnership between Health Alliance and CareSignal aims to reduce readmissions, reduce spending, and improve members’ experience whi...
Future of Healthcare
Medicago | May 06, 2022
Medicago announced the publication of the results from the Phase 3 study of COVIFENZ®, COVID-19 vaccine recombinant, adjuvanted, in the New England Journal of Medicine. The Phase 3 trial studied the two-dose regimen of COVIFENZ® given 21 days apart versus placebo in over 24,000 subjects aged 18 and above. Common side effects in the vaccine group included injection site pain, headache, fatigue, fever, muscle aches, and chills. COVIFENZ® is indicated for active immunizatio...
Healthtech Security, Healthcare Analytics
infographic
Digital Healthcare
Video
Health Technology
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE